This book has an easy, readable style and although it covers only 158 small pages of text it is a mine of detail and information. The whole spectrum of childhood malignancy is covered in a most comprehensive manner. No doubt the treatment regimes will have to be updated in the light of future developments but otherwise this book will stand the test of time. It brings a message of hope and encouragement, tempered with the advice that these patients are best treated by those with special experience. This is a book that should be read by all pediatric physicians and surgeons as well as radiotherapists, for the sake of children with cancer. 
Edinburgh &London: ChurchillLivingstone 1972
This book exemplifies the advantages and disadvantages of published symposia. All the authors are acknowledged experts in their own field (which in some cases, unfortunately, is not drug allergy) and a sense of immediacy is obtained from the printing of discussion verbatim. But no theme is developed progressively, indeed in five of the thirty-two papers it is difficult to reconcile the contents with the title of the symposium. Nevertheless, the book contains real contributions to this poorly understood matter, though it is for the specialist rather than the general reader. The number of prescriptions written by general practitioners every year is enormous. The increase has been most striking in the case of psychotropic drugs -a good index being the increase from 6.6 million prescriptions for tranquillizers in 1962 to 16 million in 1968.
This simple statement gives some indication of the relevance of Dr Wheatley's book, which examines the use and value of psychotropic drugs in family practice. This is a neglected area of research but Dr Wheatley illuminates it. In fact the bulk of psychiatric disorders are dealt with by family doctors; hospital psychiatrists treat mainly severe and chronic illness. This book is clear and to the point; it reads easily and gives an excellent account of the research carried out by Dr Wheatley and colleagues. It describes not only drug trials in general practice but also has many useful comments to make about dosage and administration. An important factual finding was the superiority of amitryptiline and chlordiazepoxide over other antidepressants and tranquillizers. There are useful comments on placebo response and a good assessment of the importance of doctors' attitudes in the treatment of emotional disorders. A valuable book which students and junior doctors will need to read as carefully as their senior colleagues.
JAMES WILLIS
Interferons and Interferon Inducers edited by N B Finter revisededition ppxx+598 Dfl80 $28.10 Amsterdam & London: North-Holland 1973 New York: American Elsevier This book is directed primarily to the needs of the graduate student and research worker. Various authors have surveyed all aspects of the subject with great care and at length. There is a good subject index and about 1700 references, and an immense amount of work has been done to make it into a useful book.
It would have been nice to have a short critical survey of the present state of affairs for the benefit of the nonspecialist or the clinician, although this information occurs scattered through the text. It seems that in spite of its discovery 16 years ago and the vast amount of work that has been done, we still do not fully understand the mechanism of action of interferon, and it shows little prospect of being really useful in human infections. The range of activity of interferon has been broadened and it has been shown to be an effective inhibitor, not only of viruses, but also of various chlamydia, protozoa, rickettsike and bacteria. Interferon can be induced by certain chlamydia, rickettsim, mycoplasmas, protozoa and bacteria, as well as by viruses, endotoxin and synthetic double stranded RNAs like poly rI;rC. Antiviral activity can readily be demonstrated in vitro and is usually demonstrable in animals, including monkeys. But the best interferon preparations have been relatively crude and human trials have been limited by the difficulty and expense of preparing large amounts of suitably purified interferon. The most suitable interferon inducer, poly rI;rC, is largely limited to superficial infection because of its toxicity. So far, the clinical trials that have been made with interferon or interferon-inducers have been disappointing.
Perhaps the problem of producing a potent, purified, inexpensive interferon will one day be overcome, but one wonders whether there is any great hope for the future. The difficulty, of course, is that by the time there are symptoms or signs of disease, virus growth in the body has been to a large extent completed, and it is too late for virus inhibitors. What is needed is enough interferon available in the right part of the body, at the right
